2 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow COD Research Private Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria Omalizumab Injection, Xolair Prefilled Syringe - Chronic Idiopathic Urticaria | Phase 3 | Completed | Kashiv BioSciences, LLC | 600 | 2023-08-15 | 2025-02-05 |
| A Clinical Study of Curcuvail® in Patients With Non-alcoholic Fatty Liver Disease Test Product: Curcuvail® 250mg capsule (Curcuma longa Extractcontaining 35% Curcuminoids), Placebo product - Fatty Liver Without Mention of Alcohol | Phase 2 | Completed | COD Research Private Ltd | 30 | 2021-01-08 | 2024-02-13 |
Diarylheptanoids (1) · Omalizumab (1)
India (2) · Jordan (1) · United States (1)